FCMI
MDCO

Foresite Capital Management IV’s Medicines Co MDCO Stock Holding History

Foresite Capital Management IV’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-403,217
Closed -$34.2M – 18
2019
Q4 		$34.2M Sell
403,217
-75,000
-16% -$5M 14.78% 2
2019
Q3 		$23.9M Buy
478,217
+228,545
+92% +$9.12M 7.73% 4
2019
Q2 		$9.11M Buy
+249,672
New +$8.15M 2.57% 14

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Foresite Capital Management IV's MDCO Position: Q1 2020 in Review

Foresite Capital Management IV sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 403,217 shares — an estimated $34.2M sold.

Foresite Capital Management IV first reported a position in MDCO in Q2 2019 and held it in 3 quarters. The position peaked at $34.2M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Foresite Capital Management IV reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Foresite Capital Management IV sold 403,217 Medicines Co shares in Q1 2020, an estimated $34.2M.
  • Foresite Capital Management IV first reported a position in Medicines Co in Q2 2019 and held it in 3 quarters.
  • Foresite Capital Management IV's Medicines Co position peaked at $34.2M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Foresite Capital Management IV's 13F filing for Q1 2020, filed 14 May 2020.